CIK: 1609805 - Address: C/O Keros Therapeutics, Inc., 1050 Waltham Street, Suite 302, Lexington, MA 02421
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret111000000NAN
P%wins100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/17/21 07:02
5/13/21
ELOXEloxx Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiNussbaum RanMADP8,0001.3505,9263157,805I
11/19/20 16:40
11/17/20
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNussbaum RanMADTP3,00050.0006063155I
4/13/20 17:16
4/13/20
KROSKeros Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsNussbaum RanMADTP.d7,00016.000437149I
7/1/19 11:50
6/27/19
ARQLArqule IncDEHealthDrugPharmaceutical PreparationsNussbaum RanMADP3,0009.75030846I
6/26/19 16:51
6/24/19
ELOXEloxx Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiNussbaum RanMADP1,8009.00020037,212I
10/22/18 14:54
7/13/18
ARQLArqule IncDEHealthDrugPharmaceutical PreparationsNussbaum RanMADP1,0005.500182121,639I
5/22/18 09:22
5/18/18
ARQLArqule IncDEHealthDrugPharmaceutical PreparationsNussbaum RanMADP.a283.290906,617I
5/18/18 17:41
5/18/18
ARQLArqule IncDEHealthDrugPharmaceutical PreparationsNussbaum RanMADP283.2909New9D
5/1/18 16:34
4/30/18
ELOXEloxx Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiNussbaum RanMADP3,4139.75035057,709I
3/23/18 16:20
3/21/18
ELOXEloxx Pharmaceuticals, Inc.DEHealthBiolabCommercial Physical & BiologiNussbaum RanMADP.m987.7601307,615I
5/11/17 14:02
5/9/17
KITEKite Pharma, Inc.DEHealthBioPrdBiological Products, (No DiagNussbaum RanCADP67969.1133105I34646443-4-8-10-80

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact